Knee Replacement clinical trials

Explore recruiting knee replacement clinical trials.

Recruiting knee replacement studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Knee Replacement trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Postoperative analgesic effect of orally administrated nefopam after a total knee arthroplasty: a randomized controlled trial (NefPO)

France

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

(PREVENT)A Randomized, Double-blind, Placebo-controlled Trial on the Prevention of Chronic Postoperative Pain after Inguinal Hernia and Knee Surgery by Postoperative Treatment with Tapentadol

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Open-Label, Active-Control Study of REGN9933, a Factor XI Monoclonal Antibody, for Prevention of Venous Thromboembolism after Elective, Unilateral, Total Knee Arthroplasty

Lithuania, Latvia, Poland, Hungary, Bulgaria, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Open-label, Active-Control Study of REGN7508, a Factor XI Monoclonal Antibody, for the Prevention of Venous Thromboembolism in Participants Undergoing an Elective, Unilateral, Total Knee Arthroplasty (ROXI-VTE II)

Bulgaria, Poland, Hungary, Latvia, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparison of the effects of prophylactic administration of Apixaban on thrombin generation in patients with de novo multiple myeloma and patients undergoing a surgery for total knee replacement: the ProApix Study

France

Therapeutic use (Phase IV) EU CTIS Study details

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Knee Replacement trials by city

Knee Replacement in Toronto Knee Replacement in Vancouver Knee Replacement in Montreal Knee Replacement in Calgary Knee Replacement in Edmonton Knee Replacement in Ottawa Knee Replacement in Winnipeg Knee Replacement in Quebec City Knee Replacement in Hamilton Knee Replacement in Kitchener Knee Replacement in London Knee Replacement in Halifax Knee Replacement in New York Knee Replacement in Los Angeles Knee Replacement in Chicago Knee Replacement in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease